Latest filing published 24 Sept 2026 for Unitedhealth Group INC.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen J. Hemsley, a Director of Unitedhealth Group Inc, has 180 filings from January 29, 2016 to September 24, 2026, all at that issuer. 15 open-market sales total EUR 365,707,332, with a median of EUR 20,719,357: each sale runs to tens of millions. The three largest are EUR 62,128,261 on October 17, 2023, EUR 52,380,788 on July 26, 2022 and EUR 45,922,810 on July 17, 2020.
A single purchase, EUR 22,352,992 on May 16, 2025, is 6% of the market trades. The record also counts 121 grants, 11 option exercises and 32 other lines.
The yearly volume is 14 to 23 filings from 2016 to 2024, then 10 in 2025 and 3 in 2026. Five filings fall in the last twelve months, with no market trade. Median publication delay: 2 days, across 177 dated filings. Richard T. Burke has trades within 30 days of 11 of Stephen J. Hemsley's trades, John F. Rex of 6, in the same direction.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 180 declarations